CA3246431A1 - INTRACANALICULAR PIECE CONTAINING A NON-STEROIDAL ANTI-INFLAMMATORY AGENT - Google Patents

INTRACANALICULAR PIECE CONTAINING A NON-STEROIDAL ANTI-INFLAMMATORY AGENT

Info

Publication number
CA3246431A1
CA3246431A1 CA3246431A CA3246431A CA3246431A1 CA 3246431 A1 CA3246431 A1 CA 3246431A1 CA 3246431 A CA3246431 A CA 3246431A CA 3246431 A CA3246431 A CA 3246431A CA 3246431 A1 CA3246431 A1 CA 3246431A1
Authority
CA
Canada
Prior art keywords
insert
sustained release
nepafenac
release biodegradable
biodegradable ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3246431A
Other languages
English (en)
French (fr)
Inventor
Charles D. Blizzard
Ankita Desai
Rami El-Hayek
Michael Goldstein
Peter Jarrett
Oktay Uzun
Original Assignee
Ocular Therapeutix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocular Therapeutix Inc filed Critical Ocular Therapeutix Inc
Publication of CA3246431A1 publication Critical patent/CA3246431A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3246431A 2022-01-09 2023-01-06 INTRACANALICULAR PIECE CONTAINING A NON-STEROIDAL ANTI-INFLAMMATORY AGENT Pending CA3246431A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263297776P 2022-01-09 2022-01-09
US63/297,776 2022-01-09
PCT/US2023/010319 WO2023133276A1 (en) 2022-01-09 2023-01-06 Intracanalicular insert comprising a non-steroidal anti-inflammatory agent

Publications (1)

Publication Number Publication Date
CA3246431A1 true CA3246431A1 (en) 2023-07-13

Family

ID=87074140

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3246431A Pending CA3246431A1 (en) 2022-01-09 2023-01-06 INTRACANALICULAR PIECE CONTAINING A NON-STEROIDAL ANTI-INFLAMMATORY AGENT

Country Status (6)

Country Link
US (1) US20250064760A1 (cg-RX-API-DMAC7.html)
EP (1) EP4460285A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025503625A (cg-RX-API-DMAC7.html)
CN (1) CN118742291A (cg-RX-API-DMAC7.html)
CA (1) CA3246431A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023133276A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104490861A (zh) * 2014-11-21 2015-04-08 三明欣茂药业有限公司 一种缓释型奈帕芬胺眼用制剂
US10603274B2 (en) * 2016-09-30 2020-03-31 Mati Therapeutics Inc. Ophthalmic drug sustained release formulation and uses thereof
AU2020262932B2 (en) * 2019-04-25 2025-11-13 Ocular Therapeutix, Inc. Intracanalicular hydrogel inserts for the delivery of anesthetics
PT3861985T (pt) * 2020-02-06 2023-08-03 Ocular Therapeutix Inc Composições e métodos para tratar doenças oculares
PT3884929T (pt) * 2020-03-25 2023-08-09 Ocular Therapeutix Inc Implante ocular contendo um inibidor da tirosina cinase
EP4216929A1 (en) * 2020-09-24 2023-08-02 Ocular Therapeutix, Inc. Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent

Also Published As

Publication number Publication date
EP4460285A4 (en) 2025-12-31
WO2023133276A1 (en) 2023-07-13
US20250064760A1 (en) 2025-02-27
EP4460285A1 (en) 2024-11-13
JP2025503625A (ja) 2025-02-04
CN118742291A (zh) 2024-10-01

Similar Documents

Publication Publication Date Title
JP2022091998A (ja) 前房内薬物送達デポ
TWI910236B (zh) 包含水凝膠及環孢菌素之持續釋放可生物降解淚小管內插入物
US20240042713A1 (en) Extruded ocular inserts or implants and methods thereof
WO2022066891A1 (en) Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent
US12453724B2 (en) Ocular implant containing a tyrosine kinase inhibitor
US20250064760A1 (en) Intracanalicular insert comprising a non-steroidal anti-inflammatory agent
US20260048008A1 (en) Organogels for sustained drug delivery, methods of preparation and use thereof
US20250114373A1 (en) Intracanalicular insert comprising an antimicrobial agent
EP4142664A1 (en) Methods of treating allergic conjunctivitis
CN118591369A (zh) 挤出式眼部插入物或植入物及其方法
CA3174217A1 (en) Ocular insert containing a glucocorticoid
US20220183969A1 (en) Ocular insert containing a glucocorticoid
WO2025255023A1 (en) Sustained release prodrug implant
HK40090731A (zh) 包含水凝胶和环孢菌素的持续释放可生物降解泪小管内插入物
BR122024018825B1 (pt) Composição de depósito e uso da mesma para tratamento de uma condição ocular

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20240703

A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20241023

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20241023

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20241023

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20241119

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241227

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241227

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241227